PACB - Pacific Biosciences of California Inc
IEX Last Trade
1.375
0.015 1.091%
Share volume: 3,997,642
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.36
0.02
1.10%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-02-28 | 2023-05-04 | 2023-08-04 | 2023-11-03 | 2024-02-28 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 1.876 B | 1.819 B | 1.767 B | 1.896 B | 1.848 B | 1.898 B | 1.746 B | 1.670 B | |
| Current Assets | 970.287 M | 913.896 M | 852.074 M | 981.111 M | 935.552 M | 882.297 M | 742.047 M | 677.024 M | |
| Inventories | 36.121 M | 43.495 M | 50.381 M | 61.955 M | 67.608 M | 68.256 M | 56.676 M | 67.343 M | |
| Other Current Assets | 7.657 M | 13.005 M | 10.289 M | 14.375 M | 13.748 M | 15.466 M | 17.040 M | 17.144 M | |
| Short Term Investments | 7.657 M | 13.005 M | 10.289 M | 14.375 M | 13.748 M | 15.466 M | 17.040 M | 17.144 M | |
| Total Receivables | 27.058 M | 22.756 M | 18.786 M | 29.589 M | 24.034 M | 30.486 M | 36.615 M | 30.323 M | |
| Current Cash | 899.151 M | 834.340 M | 772.318 M | 874.892 M | 829.862 M | 767.789 M | 631.416 M | 561.914 M | |
| Total Non-current Assets | 905.855 M | 905.053 M | 915.012 M | 915.306 M | 912.079 M | 1.016 B | 1.004 B | 992.896 M | |
| Property Plant Equipment | 37.957 M | 39.154 M | 41.580 M | 40.833 M | 40.317 M | 40.340 M | 36.432 M | 37.291 M | |
| Other Assets | 1.205 M | 1.176 M | 10.528 M | 13.319 M | 13.143 M | 13.004 M | 13.274 M | 10.119 M | |
| Intangible Assets | 410.523 M | 410.294 M | 410.245 M | 410.011 M | 409.779 M | 461.838 M | 456.984 M | 450.131 M | |
| Goodwill | 409.974 M | 409.974 M | 409.974 M | 409.974 M | 409.974 M | 463.843 M | 462.261 M | 462.261 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.876 B | 1.819 B | 1.767 B | 1.896 B | 1.848 B | 1.898 B | 1.746 B | 1.670 B | |
| Total liabilities | 1.194 B | 1.192 B | 1.204 B | 1.204 B | 1.206 B | 1.135 B | 1.045 B | 1.021 B | |
| Total current liabilities | 84.396 M | 81.649 M | 263.335 M | 265.674 M | 271.409 M | 183.961 M | 95.029 M | 72.951 M | |
| Accounts Payable | 12.883 M | 12.853 M | 12.028 M | 17.390 M | 16.512 M | 16.106 M | 15.062 M | 21.006 M | |
| Other liabilities | 167.989 M | 171.017 M | 3.094 M | 2.818 M | 5.829 M | 24.554 M | 25.831 M | 26.358 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 896.374 M | 896.529 M | 896.683 M | 896.839 M | 891.795 M | 891.996 M | 892.243 M | 892.545 M | |
| Other liabilities | 167.989 M | 171.017 M | 3.094 M | 2.818 M | 5.829 M | 24.554 M | 25.831 M | 26.358 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 681.886 M | 626.591 M | 562.904 M | 692.117 M | 641.999 M | 763.743 M | 701.304 M | 649.017 M | |
| Common stock | 224.499 M | 225.123 M | 226.289 M | 242.032 M | 250.070 M | 255.001 M | 267.413 M | 269.578 M | |
| Retained earnings | -1.371 B | -1.448 B | -1.532 B | -1.620 B | -1.690 B | -1.757 B | -1.839 B | -1.917 B |